Japan Panel Says Diovan Ads Possibly Deceptive, Ministry To Probe
This article was originally published in PharmAsia News
Executive Summary
A Japan health ministry panel issued a report saying Novartis Pharma KK may have placed deceptive advertising for its Diovan (valsartan) blood-pressure drug when it cited a now-discredited clinical study.